Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
US Army
Cantor Fitzgerald
McKesson
UBS
Dow
Harvard Business School
AstraZeneca
Merck

Generated: November 20, 2018

DrugPatentWatch Database Preview

Drugs in Development Information for Mepolizumab

« Back to Dashboard

US Patents for Mepolizumab

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Mepolizumab ➤ Sign Up Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders Knopp Biosciences LLC (Pittsburgh, PA) ➤ Sign Up
Mepolizumab ➤ Sign Up Compositions comprising oxo-derivatives of fatty acids and methods of making and using same DS BIOPHARMA LIMITED (Dublin, IE) ➤ Sign Up
Mepolizumab ➤ Sign Up Stabilizing alkylglycoside compositions and methods thereof Aegis Therapeutics LLC (San Diego, CA) ➤ Sign Up
Mepolizumab ➤ Sign Up Amorphous (5-fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl)-acetic acid Atopix Therapeutics Limited (Abingdon, Oxon, GB) ➤ Sign Up
Mepolizumab ➤ Sign Up Stabilizing alkylglycoside compositions and methods thereof Aegis Therapeutics, LLC (San Diego, CA) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Mepolizumab

Drugname Country Document Number Estimated Expiration Related US Patent
Mepolizumab Australia 2014287067 2033-07-12 ➤ Sign Up
Mepolizumab Australia 2014306597 2033-07-12 ➤ Sign Up
Mepolizumab Australia 2014306683 2033-07-12 ➤ Sign Up
Mepolizumab Australia 2017276231 2033-07-12 ➤ Sign Up
Mepolizumab Canada 2918035 2033-07-12 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
Harvard Business School
Baxter
Julphar
Moodys
Cerilliant
QuintilesIMS
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.